Page 2 - Company Phase Iib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesTheodore gerbickNavidea manoceptJosh wilsonJason myersNavidea biopharmaceuticals incCompany phase iibSecurities exchangeCardinal milestone paymentEquity lineDirector joshSecurities actSecurities exchange actAnnual report

Small Pharma Inc : Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

First placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression demonstrates rapid and durable response Primary endpoint met with a statistically significant

City ofUnited kingdomJaber mohamedEric ribnerGeorge tzirasCarol routledgeCompany or small pharmaSmall pharma incCompany phase iiaCompany phaseCompany phase iibRegulatory agencyMajor depressive disorderMontgomery asberg depression ratingChief medicalScientific officer

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first.

United kingdomNew yorkUnited statesCity ofJaber mohamedEric ribnerGeorge tzirasUniversity college londonDuration psychedelic programCompany phase iiaPads incGroup incRegulatory agencyCompany or small pharmaSmall pharma incCompany phase ib

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Small Pharma Reports Fiscal Second Quarter 2023 Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofAlastair riddellKellen jamesEric ribnerlifesci advisorsemailMarie layzellJaber mohamedmhp communicationsemailGeorge tzirasDevelopment officerCompany phase iiaCompany phaseDrug administrationResearch developmentCompany or small pharmaSmall pharma inc

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion.

United statesUnited kingdomCity ofAlastair riddellJaber mohamedKellen jamesEric ribnerMarie layzellGeorge tzirasDevelopment officerCompany phase iiaCompany phaseDrug administrationResearch developmentCompany or small pharmaSmall pharma inc